Autologous peripheral blood stem cell transplantation for primary refractory multiple myeloma.

被引：0
|
作者：
Kumar, S [1 ]
Lacy, MQ [1 ]
Dispenzieri, A [1 ]
Rajkumar, SV [1 ]
Fonseca, R [1 ]
Geyer, S [1 ]
Iturria, N [1 ]
Allmer, C [1 ]
Lust, JA [1 ]
Witzig, TE [1 ]
Greipp, PR [1 ]
Kyle, RA [1 ]
Litzow, MR [1 ]
Gertz, MA [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1674
引用
收藏
页码：432A / 433A
页数：2
相关论文
共 50 条
  • [21] Myelodysplastic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma
    D Przepiorka
    F Buadi
    B McClune
    G Franz
    W Walsh
    F White
    Bone Marrow Transplantation, 2007, 40 : 759 - 764
  • [22] Autologous transplant (AT) with peripheral-blood stem-cell rescue for multiple myeloma.: A clinical experience
    Flores, C
    Conte, G
    Fardella, P
    Araos, D
    Alfaro, J
    Aravena, P
    González, N
    Larrondo, M
    REVISTA MEDICA DE CHILE, 2005, 133 (08) : 887 - 893
  • [23] Autologous peripheral blood progenitor cell transplantation for multiple myeloma
    Attal, M
    Harousseau, JL
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 1999, 12 (1-2) : 171 - 191
  • [24] Autologous peripheral blood stem transplantation after thalidomide therapy of relapsed/refractory multiple myeloma patients
    Dmoszynska, A.
    Hus, M.
    Grzasko, N.
    Jawniak, D.
    Legiec, W.
    Wach, M.
    Cioch, M.
    Manko, J.
    Walter-Croneck, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S324 - S324
  • [25] Autologous blood stem cell transplantation with CeprateR selected CD34+ cells for multiple myeloma.
    Volin, L
    Juvonen, E
    Elonen, E
    Ruutu, T
    BONE MARROW TRANSPLANTATION, 1998, 21 : S204 - S204
  • [26] High-dose lenalidomide and melphalan as conditioning for autologous stem cell transplantation in relapsed or refractory multiple myeloma.
    Rossi, Adriana C.
    Monge, Jorge
    Niesvizky, Ruben
    Hsu, Jing Mei
    Shore, Tsiporah
    Van Besien, Koen
    Pearse, Roger
    Mark, Tomer
    Jayabalan, David
    Mayer, Sebastian Alexander
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] Second autologous stem cell transplantation as a strategy for management of relapsed multiple myeloma.
    Gonsalves, Wilson I.
    Kumar, Shaji
    Lacy, Martha
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Buadi, Francis
    Dingli, David
    Hogan, William J.
    Gertz, Morie A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Natural history of relapse after autologous stem cell transplantation for multiple myeloma.
    McClune, B
    Buadi, F
    Yunus, F
    Minhas, S
    Walsh, W
    Przepiorka, D
    BLOOD, 2005, 106 (11) : 466B - 466B
  • [29] Autologous stem cell transplantation improves abnormal bone turnover in multiple myeloma.
    Terpos, E
    Hatziharissi, E
    Szydlo, R
    de la Fuente, J
    Karadimitris, A
    Kanfer, E
    Olavarria, E
    Goldman, JM
    Apperley, JF
    Rahemtulla, A
    BLOOD, 2002, 100 (11) : 434A - 434A
  • [30] Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma
    Veltri, Lauren W.
    Milton, Denai R.
    Delgado, Ruby
    Shah, Nina
    Patel, Krina
    Nieto, Yago
    Kebriaei, Partow
    Popat, Uday R.
    Parmar, Simrit
    Oran, Betul
    Ciurea, Stefan
    Hosing, Chitra
    Lee, Hans C.
    Manasanch, Elisabet
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    Bashir, Qaiser
    CANCER, 2017, 123 (18) : 3568 - 3575
12345